Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Sensors (Basel, Switzerland)
|
June 2, 2021
Field-Portable Microplastic Sensing in Aqueous Environments: A Perspective on Emerging Techniques
Morgan G Blevins, Harry L Allen, Beckett C Colson, et al.
Annals of Internal Medicine
|
February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Nadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Leukemia
|
February 23, 2016
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
A Larocca, S Bringhen, M T Petrucci, et al.
Science Translational Medicine
|
December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Peter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
Nature Communications
|
June 24, 2018
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
César López-Camacho, Peter Abbink, Rafael A Larocca, et al.
Nature
|
June 30, 2016
Vaccine protection against Zika virus from Brazil
Rafael A Larocca, Peter Abbink, Jean Pierre S Peron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Lancet (London, England)
|
December 9, 2017
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad, Leyi Lin, Sarah L George, et al.
Science (New York, N.Y.)
|
August 6, 2016
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Peter Abbink, Rafael A Larocca, Rafael A De La Barrera, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Sensors (Basel, Switzerland)
|
June 2, 2021
Field-Portable Microplastic Sensing in Aqueous Environments: A Perspective on Emerging Techniques
Morgan G Blevins, Harry L Allen, Beckett C Colson, et al.
Annals of Internal Medicine
|
February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Nadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Leukemia
|
February 23, 2016
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
A Larocca, S Bringhen, M T Petrucci, et al.
Science Translational Medicine
|
December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
Peter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
Nature Communications
|
June 24, 2018
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
César López-Camacho, Peter Abbink, Rafael A Larocca, et al.
Nature
|
June 30, 2016
Vaccine protection against Zika virus from Brazil
Rafael A Larocca, Peter Abbink, Jean Pierre S Peron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Lancet (London, England)
|
December 9, 2017
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad, Leyi Lin, Sarah L George, et al.
Science (New York, N.Y.)
|
August 6, 2016
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Peter Abbink, Rafael A Larocca, Rafael A De La Barrera, et al.
Page
of 9